Cooperation with the outside world

Project: “Phase III, Double-Blind, Randomized, Placebo-Controlled, Trial to Investigate the Efficacy, Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TVD) Administered Subcutaneouly in Heath Children Aged 4-16 Years Old”

Institution / Company: PPD Development, LP (Wilmington, USA)
Sponsor: Takeda Vaccines

Coordinator: Rivaldo Venâncio da Cunha

Project: “CYD 15 – Efficacy and safety of a new dengue tetravalent vaccine in healthy children and adolescents aged 9 to 16 years in Latin America”

Sponsor: Sanofi Pasteur, INC (Swiftwater, USA)

Coordinator: Rivaldo Venâncio da Cunha

Project:  “OMNIA” Brazil/Italy Network: Promotion of the Reorientation of Career and Technical Training in Health”

Institutions: University of Torino (Italy), Hospital São Julião (Campo Grande, Brazil) and Lauro de Souza Lima Institute (Bauru, Brazil)

Coordinator: James Venturini

Project:  “Surveillance of resistance of Aspergillus spp to azole antifungals in the State of Mato Grosso do Sul”.

Institution / Company: University of Leuven (Leuven, Belgium) and Centers of Diseases Control and Prevention (CDC, Atlanta, USA)

Coordinator: James Venturini

Project: “Pulmonary fibrosis in paracoccidioidomycosis: fibrogenesis, biomarkers and new therapeutic targets”.

Institution / Company: Rheinisch-Westfälische Technische Hochschule (RWTH, Aachen, Germany)

Coordinator: James Venturini